BioCentury
ARTICLE | Clinical News

Lyrica regulatory update

February 23, 2017 2:15 AM UTC

Pfizer and Eisai Co. Ltd. (Tokyo:4523, Tokyo, Japan) said Japan approved Lyrica pregabalin oral disintegrating (OD) tablets to treat neuropathic pain and pain associated with fibromyalgia. The GABA r...

BCIQ Company Profiles

Eisai Co. Ltd.

Pfizer Inc.

BCIQ Target Profiles

GABA receptor